Remidose Aerosols Inc.
PrivateLast Round
Accelerator
Aug 27, 2021
Total Funding Raised
$60,000
Company Overview
Remidose Aerosols Inc. operates in Healthcare & Life Sciences and is based in Stratford. Its latest recorded funding round was an Accelerator round in August 2021.
Remidose Aerosols Inc. is a cannabis company that manufactures medical devices and cannabis-based products, including metered-dose inhalers and topical formulations.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Remidose Aerosols Inc. Comparables
Compare Remidose Aerosols Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Syqe Medical | 78% | |
| Roxx Labs | 75% | |
| Medipharm Labs Corp | 72% |
For institutional investors. Book with your work email.
Remidose Aerosols Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Aug 27, 2021 | ||||
| Grant | Jul 26, 2021 | ||||
| Grant | Dec 18, 2020 |
For institutional investors. Book with your work email.
Remidose Aerosols Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Atlantic Canada Opportunities Agency | Grant |
| Emergence Incubator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2021
$40K grant received from Atlantic Canada Opportunities Agency.
For institutional investors. Book with your work email.
Remidose Aerosols Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Remidose Aerosols Inc.'s valuation, stock price, and market status.
Is Remidose Aerosols Inc. a public or private company?
Remidose Aerosols Inc. is a private company.
What is the current stock price of Remidose Aerosols Inc.?
Remidose Aerosols Inc. is a private company, so its shares have no public market price. Caplight tracks Remidose Aerosols Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Remidose Aerosols Inc. worth (valuation)?
Valuation information for Remidose Aerosols Inc. is not publicly available.
Can I buy Remidose Aerosols Inc. stock?
Remidose Aerosols Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Remidose Aerosols Inc.'s last funding round?
Remidose Aerosols Inc.'s most recent funding round was Accelerator on August 27, 2021.
Who are the main investors in Remidose Aerosols Inc.?
Key investors in Remidose Aerosols Inc. include Atlantic Canada Opportunities Agency, Emergence Incubator.
Will Remidose Aerosols Inc. IPO soon?
No public IPO plans have been announced for Remidose Aerosols Inc..
How can I track Remidose Aerosols Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Remidose Aerosols Inc.'s shares on secondary markets.